BioElectronic's ActiPatch(TM) Product Chosen as 'One of 9 Medical Breakthroughs That May Change Your Life'

Tuesday, July 8, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

FREDERICK, Md., July 7 ActiPatch(TM), theproduct marketed by Bioelectronics Corp. (Pink Sheets: BIEL), is changing theface of medicine and the way we heal. Recently chosen as "One of 9 MedicalBreakthroughs That May Change Your Life," by, ActiPatch isfast becoming the treatment of choice for everything from soft tissue injuriesto surgical recovery.

"The decision to include ActiPatch in the top 9 medical breakthroughs wasan easy one," said Reginald Saxton, President of Medical Headway. "ActiPatchfills the void created by consumers who would rather not take pain medicationsand are seeking safe and effective alternative treatment options," Saxtonadded, "I knew our readers would be very interested in this product for thatreason".

ActiPatch is a drug-free wafer thin patch with an embedded batteryoperated microchip that delivers weeks of continuous pulsed RF therapy forless than a dollar a day. The unique ActiPatch delivery system, using patentedtechnology, provides a cost-effective, home use method that reduces softtissue pain and swelling, and accelerates healing.

When using ActiPatch, bruises that would normally take three weeks to healoften heal in a week; ankle sprains usually respond positively with reducedpain and swelling in only a single day; plastic surgery incisions that wouldnormally take weeks to heal typically heal in less than a week. These claimsare supported by multiple clinical trials and strong endorsements from leadingsurgeons and physicians.

BioElectronics has already received FDA clearance for one surgicalprocedure, (blepharoplasty), and is now able to sell the product within theUnited States through physician referral. In addition, BioElectronics hasreceived blanket approval in the European Union, Canada, and dozens ofcountries. These international approvals have allowed the product to be placedin stores for over-the-counter purchase outside the United States.

Andrew J. Whelan, CEO of BioElectronics Corporation, explains, "ActiPatchwith its non-invasive, very efficient treatment for swelling and pain whileaccelerating recovery is the medicine of the future available today. We areactively pursuing additional reimbursement approvals nationally. ActiPatch isan important product that not only works without side-effects, it also has thepotential to help keep medical costs down at a time when they appear to bespiraling out of control," adds Whelan. is an online medical breakthrough library published byMedical Headway, LLC of Houston, TX. Dedicated to arming the public with newsof the latest breakthroughs in the world of medicine, the company offersconsumers free and complete access to its growing library of cutting-edge,professional medical treatment and product information. "In our opinion,ActiPatch is a huge advance for millions of people who would rather not take apill or who need faster pain relief ... a clear breakthrough everyone shouldknow about," explains Saxton.

For more information visit or call866-757-2284.

About BioElectronics Corporation

BioElectronics Corporation is the maker of the ActiPatch(TM). ActiPatch isa drug-free anti-inflammatory patch with an embedded battery operatedmicrochip that delivers weeks of continuous pulsed therapy for about a dollara day. The unique ActiPatch delivery system, using patented technology,provides a cost-effective patient friendly method to reduce soft tissue painand swelling. ActiPatch is approved by Health Canada for the relief of pain inmusculoskeletal complaints. The US government's food and drug administration(FDA) has cleared the use of the product for reducing edema (swelling)following blepharoplasty and the European Union has approved the product as aclass two pulsed electromagnetic medical device as have numerous otherinternational record for agencies. <

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store